{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:52:20Z","timestamp":1794243140999,"version":"4.9.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00296-017-3728-z","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T15:53:54Z","timestamp":1493222034000},"page":"1203-1206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Squamous cell carcinoma of the lung associated with anti-Jo1 antisynthetase syndrome: a case report and review of the literature"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5891-1868","authenticated-orcid":false,"given":"G.","family":"Boleto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Perotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Eschard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-H.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,26]]},"reference":[{"key":"3728_CR1","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/rheumatology\/kep455","volume":"49","author":"B Hervier","year":"2010","unstructured":"Hervier B, Wallaert B, Hachulla E, Adoue D, Lauque D, Audrain M et al (2010) Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases. Rheumatology 49:972\u2013976","journal-title":"Rheumatology"},{"key":"3728_CR2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/acr.21895","volume":"65","author":"I Marie","year":"2013","unstructured":"Marie I, Josse S, Hatron PY, Dominique S, Hachulla E, Janvresse A et al (2013) Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome. Arthritis Care Res 65:800\u2013808","journal-title":"Arthritis Care Res"},{"key":"3728_CR3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11926-002-0087-9","volume":"4","author":"R Buchbinder","year":"2002","unstructured":"Buchbinder R, Hill CL (2002) Malignancy in patients with inflammatory myopathy. Curr Rheumatol Rep 4:415\u2013426","journal-title":"Curr Rheumatol Rep"},{"key":"3728_CR4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.autrev.2011.10.024","volume":"11","author":"I Marie","year":"2012","unstructured":"Marie I, Guillevin L, Menard J-F, Hatron PY, Cherin P, Amoura Z et al (2012) Hematological malignancy associated with polymyositis and dermatomyositis. Autoimmun Rev 11:615\u2013620","journal-title":"Autoimmun Rev"},{"key":"3728_CR5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A et al (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. The Lancet 357:96\u2013100","journal-title":"The Lancet"},{"key":"3728_CR6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1297-319X(03)00012-5","volume":"70","author":"A Imbert-Masseau","year":"2003","unstructured":"Imbert-Masseau A, Hamidou M, Agard C, Grolleau JY, Ch\u00e9rin P (2003) Antisynthetase syndrome. Jt Bone Spine 70:161\u2013168","journal-title":"Jt Bone Spine"},{"key":"3728_CR7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2012.06.006","volume":"12","author":"B Hervier","year":"2012","unstructured":"Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, Masseau A et al (2012) Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev 12:210\u2013217","journal-title":"Autoimmun Rev"},{"key":"3728_CR8","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","volume":"41","author":"I Marie","year":"2012","unstructured":"Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard J-F et al (2012) Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody. Semin Arthritis Rheum 41:890\u2013899","journal-title":"Semin Arthritis Rheum"},{"key":"3728_CR9","first-page":"1858","volume":"30","author":"Y Iwasaki","year":"1992","unstructured":"Iwasaki Y, Mohri T, Muraki M, Yasukawa A, Fujimoto T, Takagi O (1992) et al [A case of interstitial pneumonitis associated with polymyositis complicated by renal cell carcinoma]. Nihon Ky\u014dbu Shikkan Gakkai Zasshi 30:1858\u20131863","journal-title":"Nihon Ky\u014dbu Shikkan Gakkai Zasshi"},{"key":"3728_CR10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/rheumatology\/keg473","volume":"43","author":"J Watkins","year":"2004","unstructured":"Watkins J, Farzaneh-Far R, Tahir H, Wykes F, Studdy PR, Beynon HLC (2004) Jo-1 syndrome with associated poorly differentiated adenocarcinoma. Rheumatol Oxf 43:389\u2013390","journal-title":"Rheumatol Oxf"},{"key":"3728_CR11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejim.2004.11.020","volume":"16","author":"AE Bijl van der","year":"2005","unstructured":"van der Bijl AE, Meinders AE, van Duinen SG, Tamsma JT (2005) A nasal squamous cell carcinoma complicated by a paraneoplastic syndrome consisting of a myositis and anti-Jo-1 autoantibodies. Eur J Intern Med 16:369\u2013371","journal-title":"Eur J Intern Med"},{"key":"3728_CR12","first-page":"289","volume":"52","author":"S Nakanishi","year":"2006","unstructured":"Nakanishi S (2006) Hatayama T [Adenocarcinoma of the prostate associated with anti Jo-1 antibody positive polymyositis]. Hinyokika Kiyo 52:289\u2013291","journal-title":"Hinyokika Kiyo"},{"key":"3728_CR13","first-page":"151","volume":"71","author":"G Respicio","year":"2007","unstructured":"Respicio G, Shwaiki W, Abeles M (2007) A 58-year-old man with anti-Jo-1 syndrome and renal cell carcinoma: a case report and discussion. Conn Med 71:151\u2013153","journal-title":"Conn Med"},{"key":"3728_CR14","first-page":"169","volume":"35","author":"D Legault","year":"2008","unstructured":"Legault D, McDermott J, Crous-Tsanaclis AM, Boire G (2008) Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome. J Rheumatol 35:169\u2013171","journal-title":"J Rheumatol"},{"key":"3728_CR15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/RHU.0b013e31817d116f","volume":"14","author":"A Rozelle","year":"2008","unstructured":"Rozelle A, Trieu S, Chung L (2008) Malignancy in the setting of the anti-synthetase syndrome. J Clin Rheumatol 14:285\u2013288","journal-title":"J Clin Rheumatol"},{"key":"3728_CR16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.20452\/pamw.336","volume":"118","author":"G Przybylski","year":"2008","unstructured":"Przybylski G, Jarzemska A, Czerniak J, Siemiatkowska K, Gadzi\u0144ska A, Cie\u015bli\u0144ski K (2008) A case report of a patient with dermatomyositis as a prodromal sign of lung cancer. Pol Arch Med Wewn\u0119trznej 118:143\u2013147","journal-title":"Pol Arch Med Wewn\u0119trznej"},{"key":"3728_CR17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/RHU.0b013e3181b0e910","volume":"15","author":"LM Mileti","year":"2009","unstructured":"Mileti LM, Strek ME, Niewold TB, Curran JJ, Sweiss NJ (2009) Clinical characteristics of patients with anti-Jo-1 antibodies: a single center experience. J Clin Rheumatol 15:254\u2013255","journal-title":"J Clin Rheumatol"},{"key":"3728_CR18","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/RHU.0b013e31823b1878","volume":"17","author":"M Casta\u00f1eda-Pomeda","year":"2011","unstructured":"Casta\u00f1eda-Pomeda M, Prieto-Gonz\u00e1lez S, Grau JM (2011) Antisynthetase syndrome and malignancy: our experience. J Clin Rheumatol 17:458","journal-title":"J Clin Rheumatol"},{"key":"3728_CR19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jbspin.2010.08.018","volume":"78","author":"M Vincze","year":"2011","unstructured":"Vincze M, Moln\u00e1r PA, Zilahi E, Kapit\u00e1ny A, Dezso B, Tak\u00e1cs I et al (2011) Primary lung adenocarcinoma associated with anti-Jo-1 positive polymyositis. Jt Bone Spine 78:209\u2013211","journal-title":"Jt Bone Spine"},{"key":"3728_CR20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.reuma.2012.07.002","volume":"9","author":"L Bragado","year":"2013","unstructured":"Bragado L, Ruiz Guti\u00e9rrez L, Cuende E, L\u00f3pez Gonz\u00e1lez JL (2013) Kaposi\u2019s sarcoma in a steroid-treated antisynthethase antibody syndrome patient. Reumatol Clin 9:243\u2013245","journal-title":"Reumatol Clin"},{"key":"3728_CR21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.revmed.2013.04.012","volume":"35","author":"A Courties","year":"2014","unstructured":"Courties A, Lidove O, Maisonobe T, Rigolet A, Hermet A, Girard P (2014) et al [Antisynthetase syndrome and lung carcinoma: a fortuitous association?]. Rev M\u00e9d Intern 35:271\u2013273","journal-title":"Rev M\u00e9d Intern"},{"key":"3728_CR22","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/ar4332","volume":"15","author":"I Marie","year":"2013","unstructured":"Marie I, Hatron P-Y, Cherin P, Hachulla E, Diot E, Vittecoq O et al (2013) Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome. Arthritis Res Ther 15:R149","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"3728_CR23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.semarthrit.2016.03.011","volume":"46","author":"E Trallero-Aragu\u00e1s","year":"2016","unstructured":"Trallero-Aragu\u00e1s E, Grau-Junyent JM, Labirua-Iturburu A, Garc\u00eda-Hern\u00e1ndez FJ, Monteagudo-Jim\u00e9nez M, Fraile-Rodriguez G et al (2016) Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group. Semin Arthritis Rheum 46(2):225\u2013231","journal-title":"Semin Arthritis Rheum"},{"key":"3728_CR24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.autrev.2012.01.006","volume":"11","author":"I Marie","year":"2012","unstructured":"Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C et al (2012) Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 11:739\u2013745","journal-title":"Autoimmun Rev"},{"key":"3728_CR25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08916930600623791","volume":"39","author":"RL Corte","year":"2006","unstructured":"Corte RL, naco ALM, Locaputo A, Dolzani F, Trotta F (2006) In patients with antisynthetase syndrome the occurrence of anti-Ro\/SSA antibodies causes a more severe interstitial lung disease. Autoimmunity 39:249\u2013253","journal-title":"Autoimmunity"},{"key":"3728_CR26","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/annrheumdis-2011-200182","volume":"71","author":"H Chinoy","year":"2012","unstructured":"Chinoy H, Adimulam S, Marriage F, New P, Vincze M, Zilahi E et al (2012) Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis 71:961\u2013965","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3728-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3728-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3728-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:36:24Z","timestamp":1750206984000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3728-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,26]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["3728"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3728-z","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,26]]}}}